GILTERITINIB

4079 reported adverse events

These side effects are most commonly reported by patients taking GILTERITINIB:

# Side effect Count
0 OFF LABEL USE 508
1 ACUTE MYELOID LEUKAEMIA 342
2 MYELOSUPPRESSION 312
3 PLATELET COUNT DECREASED 298
4 PNEUMONIA 282
5 DEATH 273
6 PYREXIA 261
7 PRODUCT USE ISSUE 254
8 FEBRILE NEUTROPENIA 252
9 ACUTE MYELOID LEUKAEMIA RECURRENT 180
See all common reactions for GILTERITINIB

GILTERITINIB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 WT1 GENE MUTATION 7 0.7778
1 PLATELET-DERIVED GROWTH FACTOR RECEPTOR GENE MUTATION 3 0.5000
2 BILIARY TRACT INFECTION FUNGAL 4 0.4444
3 METAMYELOCYTE PERCENTAGE 2 0.4000
4 GENE MUTATION IDENTIFICATION TEST NEGATIVE 4 0.3077
5 TUMOUR CELL MOBILISATION 3 0.3000
6 FLT3 GENE MUTATION 4 0.2667
7 METAMYELOCYTE COUNT 2 0.2500
8 LEFT ATRIAL HYPERTROPHY 11 0.2200
9 GRAFT VERSUS HOST DISEASE ORAL 9 0.1406
See all enriched reactions for GILTERITINIB